Reports

Global Companion Diagnostics Market to Grow at a CAGR of 26% over the Forecast Period of 2021-2026.

Companion Diagnostics Market

Global Companion Diagnostics Market Size, Share, Forecast: By Product and Service: Assay Kits and Reagents, Software and Services; By Technology: Polymerase Chain Reaction, Immunohistochemistry, In Situ Hybridization, Other Technologies; By Indication; By End Use; Regional Analysis; Competitive Landscape; 2024-2032

Global Companion Diagnostics Market Outlook

The global companion diagnostics market size stood at a value of USD 7.37 billion in 2023. The companion diagnostics market is expected to achieve USD 19.54 billion by 2032, growing at a CAGR of 11.4% between the forecast period of 2024 and 2032.

 

Companion Diagnostics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The companion diagnostics industry is anticipated to grow significantly during the forecast period due to an increase in R&D of targeted therapies for cancer, along with the increasing demand for personalised medicine.

 

Market Segmentation

A companion diagnostic is a medical in-vitro device that offers data for the secure and efficient use of a drug and determines its applicability to a specific person. This diagnostic test enables a medical specialist to determine whether a specific therapeutic product helps patients or not, outweighing any severe potential side effects or hazards. The industry can be divided based on its product and services into assay kits and reagents, and software and services.

 

Companion Diagnostics Market By Segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry can be broadly categorised based on its end-use into:

  • Pharmaceutical and Biopharmaceutical Companies 
  • Reference Laboratories 
  • Other

The industry can be divided based on its technology as polymerase chain reaction, immunohistochemistry, in situ hybridization, and next-generation sequencing, among others.

The industry can be divided based on indication as:

  • Oncology 
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Gastric Cancer
  • Other Cancers
  • Neurology 
  • Infectious Diseases 
  • Other Indications

The EMR report looks into the regional companion diagnostics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Companion Diagnostics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The increased popularity of personalised medicines, rising cases of adverse drug reactions (ADRs) and higher number of unmet needs for treating cancer are the driving factors, accelerating the growth of the companion diagnostics market. An increase in healthcare expenditure, globally, and technological advancements in diagnostic techniques are propelling the positive growth of the industry. With rising awareness, particularly in developing economies, along with the discovery of new biomarkers for diverse conditions, the industry is witnessing a further growth. The growth of the companion animal diagnostics market will also propel the growth of the overall companion diagnostics industry. The cases of cancer is expected drive the growth of the companion diagnostics industry in the oncology segment. The approval of companion diagnostics by government agencies like the FDA is expected to drive the growth of the industry. Unfavourable reimbursement policies in some countries may affect the companion diagnostics market growth during the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following leading companies in the global companion diagnostics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche AG
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc. 
  • Abbott Laboratories, Inc. 
  • Biomérieux SA 
  • Danaher Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product & Service, Technology, Indication, End Use, Region
Breakup by Product & Service Assay Kits and Reagents, Software and Services
Breakup by Technology Polymerase Chain Reaction, Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing, Other Technologies
Breakup by Indication Oncology, Neurology
Breakup by End Use Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Other End Users
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Biomérieux SA, Danaher Corporation, Illumina, Inc., Myriad Genetics, Inc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description
    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary
    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Companion Diagnostics Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Companion Diagnostics Historical Market (2018-2023) 
    8.3    Global Companion Diagnostics Market Forecast (2024-2032)
    8.4    Global Companion Diagnostics Market by Product and Service
        8.4.1    Assay Kits and Reagents 
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
        8.4.2    Software and Services
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
    8.5    Global Companion Diagnostics Market by Technology
        8.5.1    Polymerase Chain Reaction 
            8.5.1.1    Historical Trend (2018-2023)
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Immunohistochemistry 
            8.5.2.1    Historical Trend (2018-2023)
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    In Situ Hybridization 
            8.5.3.1    Historical Trend (2018-2023)
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Next-Generation Sequencing 
            8.5.4.1    Historical Trend (2018-2023)
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Other Technologies 
    8.6    Global Companion Diagnostics Market by Indication
        8.6.1    Oncology 
            8.6.1.1    Historical Trend (2018-2023)
            8.6.1.2    Forecast Trend (2024-2032)
            8.6.1.3    Breakup by Type
                8.6.1.3.1    Breast Cancer
                8.6.1.3.2    Lung Cancer
                8.6.1.3.3    Colorectal Cancer
                8.6.1.3.4    Melanoma
                8.6.1.3.5    Gastric Cancer
                8.6.1.3.6    Other Cancers
        8.6.2    Neurology 
            8.6.2.1    Historical Trend (2018-2023)
            8.6.2.2    Forecast Trend (2024-2032)
            8.6.2.3    Breakup by Type
                8.6.2.3.1    Infectious Diseases 
                8.6.2.3.2    Other Indications
    8.7    Global Companion Diagnostics Market by End Use
        8.7.1    Pharmaceutical and Biopharmaceutical Companies 
            8.7.1.1    Historical Trend (2018-2023)
            8.7.1.2    Forecast Trend (2024-2032)
        8.7.2    Reference Laboratories 
            8.7.2.1    Historical Trend (2018-2023)
            8.7.2.2    Forecast Trend (2024-2032)
        8.7.3    Other End Users
    8.8    Global Companion Diagnostics Market by Region     
      8.8.1    North America
          8.8.1.1    Historical Trend (2018-2023) 
          8.8.1.2    Forecast Trend (2024-2032)
      8.8.2    Europe
          8.8.2.1    Historical Trend (2018-2023) 
          8.8.2.2    Forecast Trend (2024-2032)
      8.8.3    Asia Pacific
          8.8.3.1    Historical Trend (2018-2023) 
          8.8.3.2    Forecast Trend (2024-2032)    
      8.8.4    Latin America
          8.8.4.1    Historical Trend (2018-2023) 
          8.8.4.2    Forecast Trend (2024-2032)
      8.8.8    Middle East and Africa
          8.8.8.1    Historical Trend (2018-2023) 
          8.8.8.2    Forecast Trend (2024-2032)
9    North America Companion Diagnostics Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Companion Diagnostics Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Companion Diagnostics Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Companion Diagnostics Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and  Africa Companion Diagnostics Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    F. Hoffmann-La Roche Ltd
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Agilent Technologies, Inc. 
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Thermo Fisher Scientific, Inc. 
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Abbott Laboratories, Inc. 
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Illumina, Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Companion Diagnostics Market: Key Industry Highlights, 2018 and 2032
2.    Global Companion Diagnostics Historical Market: Breakup by Product and Service (USD Million), 2018-2023
3.    Global Companion Diagnostics Market Forecast: Breakup by Product and Service (USD Million), 2024-2032
4.    Global Companion Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
5.    Global Companion Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6.    Global Companion Diagnostics Historical Market: Breakup by Indication (USD Million), 2018-2023
7.    Global Companion Diagnostics Market Forecast: Breakup by Indication (USD Million), 2024-2032
8.    Global Companion Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
9.    Global Companion Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10.    Global Companion Diagnostics Historical Market: Breakup by Region (USD Million), 2018-2023
11.    Global Companion Diagnostics Market Forecast: Breakup by Region (USD Million), 2024-2032
12.    North America Companion Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
13.    North America Companion Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Europe Companion Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Europe Companion Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Asia Pacific Companion Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
17.    Asia Pacific Companion Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
18.    Latin America Companion Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
19.    Latin America Companion Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
20.    Middle East and Africa Companion Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
21.    Middle East and Africa Companion Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
22.    Global Companion Diagnostics Market Structure

Key Questions Answered in the Report

What was the global companion diagnostics market size in 2023?

The global companion diagnostics market attained a USD 7.37 billion in 2023.

What is the growth rate of the global companion diagnostics market?

The market is projected to grow at a CAGR of 11.4% in the forecast period of 2024-2032.

What are the major market drivers?

The major market drivers include advancements in diagnostic techniques, the increasing popularity of personalised medicines, the surging approvals of companion diagnostics by government agencies, the discovery of new biomarkers for diverse conditions, and rising cases of cancer.

What are the key trends of the global companion diagnostics market?

Increase in healthcare expenditure, globally, and rising cases of adverse drug reactions (ADRs) are the key trends propelling the market growth.

What are the major regions of companion diagnostics, according to the EMR report?

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the major regions in the market.

What are the leading products and services in the market?

The leading products and services of companion diagnostics are assay kits and reagents and software and services.

What are the major technologies of the product in the market?

The major technologies of the product are polymerase chain reaction, immunohistochemistry, in situ hybridisation, and next-generation sequencing, among other technologies.

What are the significant indications of the product in the market?

The significant indications of companion diagnostics are oncology and neurology.

What are the major end-use segments for the market?

The major end-use segments for the market include pharmaceutical and biopharmaceutical companies and reference laboratories, among other end users.

Who are the key market players according to the report?

The major players in the market are F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., and Illumina, Inc., among others.
 

Analyst Review

The global companion diagnostics market attained a value of USD 7.37 billion in 2023 driven by the increasing popularity of personalised medicines. Aided by the increasing in healthcare expenditure, globally, and technological advancements in diagnostic techniques, the market is expected to further grow at CAGR of 11.4% in the forecast period of 2024-2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. On the basis of products and services, the market is divided into assay kits and reagents and software and services. Based on the technologies, the industry can be segmented into polymerase chain reaction, immunohistochemistry, in situ hybridization, and next-generation sequencing, among other technologies. On the basis of indication, the market is bifurcated into oncology and neurology. Oncology is sub-divided into breast cancer, lung cancer, colorectal cancer, melanoma, and gastric cancer, among other cancers whereas neurology is further divided into infectious diseases and other indications. Based on end-use sector, the market can be categorised into pharmaceutical and biopharmaceutical companies and reference laboratories, among other end users. The major regional markets for the product are North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa. The key players in the above industry include F. Hoffmann-La Roche AG, Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Biomérieux SA, Danaher Corporation, Illumina, Inc., and Myriad Genetics, Inc among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER